{{Rsnum
|rsid=12589592
|Chromosome=14
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=FBLN5
|position=91911458
|Gene_s=FBLN5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 48.7 | 39.8
| HCB | 11.7 | 46.0 | 42.3
| JPT | 14.2 | 43.4 | 42.5
| YRI | 0.0 | 13.6 | 86.4
| ASW | 0.0 | 22.8 | 77.2
| CHB | 11.7 | 46.0 | 42.3
| CHD | 16.5 | 47.7 | 35.8
| GIH | 7.9 | 35.6 | 56.4
| LWK | 0.9 | 22.7 | 76.4
| MEX | 1.7 | 46.6 | 51.7
| MKK | 1.3 | 18.6 | 80.1
| TSI | 1.0 | 48.0 | 51.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24917111
|Title=Fibulin-5 (FBLN5) gene polymorphism is associated with pelvic organ prolapse
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}